The impact of efficacy of long-acting injectable antipsychotics on caregivers’ burden of patients with schizophrenia-Reference-Cited by-同舟云学术

The impact of efficacy of long-acting injectable antipsychotics on caregivers’ burden of patients with schizophrenia

Published:2024-02-22 Issue:5 Volume:39 Page:333-335
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Capuzzi Enrico¹,Quitadamo Cecilia²,Caldiroli Alice¹,Clerici Massimo¹²,Buoli Massimiliano³⁴

Affiliation:

1. Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori

2. Department of Medicine and Surgery, University of Milan Bicocca, Monza (MB)

3. Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico

4. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference16 articles.

1. High rate of discontinuation during long-acting injectable antipsychotic treatment in patients with psychotic disorders.;Auxilia;Biomedicines,2023

2. Predictive factors of treatment resistance in first episode of psychosis: a systematic review.;Bozzatello;Front Psychiatry,2019

3. The Relation between the plasma concentrations of long-acting atypical antipsychotics and clinical effectiveness in patients affected by schizophrenia or schizoaffective disorder: a comprehensive overview.;Capuzzi;Curr Pharm Des,2021

4. Experimental serotonergic agents for the treatment of schizophrenia.;Capuzzi;J Exp Pharmacol,2021

5. Sociodemographic and clinical factors associated with prescription of first- versus second-generation long-acting antipsychotics in incarcerated adult males.;Capuzzi;Int Clin Psychopharmacol,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mood disorders and somatic comorbidities;International Clinical Psychopharmacology;2024-07-31

2. Focus on neurodevelopmental conditions and antipsychotics prescription patterns;International Clinical Psychopharmacology;2024-05-29